通过MTHFD2调节的氧化还原稳定在低氧条件下促进胃癌的进展
Hai-Yu Mo1,2, Ruo-Bing Wang1, Meng-Yao Ma1
1Department of Medical Biochemistry and Molecular Biology, School of Medicine, Jinan University, Guangzhou, People's Republic of China.
概括
在氧化应激下,MTHFD2过度表达有助于胃癌的生存. 抑制MTHFD2可以减少瘤生长,为这种癌症提供潜在的治疗策略.
科学领域:
- 在瘤学瘤学.
- 代谢途径 代谢途径
- 转毒生物学 转毒生物学
背景情况:
- 胃癌 (GC) 细胞通过代谢重编程适应氧化应激.
- 在GC中,将新陈代谢重塑与在活性氧物种 (ROS) 压力下生存的机制尚未完全理解.
研究的目的:
- 确定保护GC细胞免受氧化应激的关键代谢酶.
- 研究MTHFD2在胃癌进展和生存中的作用.
主要方法:
- 使用DCFH-DA探头评估ROS水平.
- 进行了细胞生物学研究以阐明机制.
- 通过基于细胞和患者衍生的异种移植 (PDX) 模型评估了MTHFD2的体内作用.
主要成果:
- MTHFD2过度表达与GC患者的整体和无病生存率较差相关.
- 在MTHFD2中,降低了NADPH/NADP+比率,殖民地形成和线粒体功能.
- 在细胞系和PDX模型中,MTHFD2抑制降低了瘤负担.
结论:
- 在胃癌中,MTHFD2在氧化还原调节和瘤进展中起着至关重要的作用.
- 向MTHFD2证明了胃癌治疗的治疗潜力.
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Electron Transport Chain: Complex I and II
13.1K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
13.1K
Gastritis-II: Pathophysiology
320
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
320
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K


